Russian COVID vaccine: why more and more countries are turning to Sputnik V
By Sarah Schiffling, Senior Lecturer in Supply Chain Management, Liverpool John Moores University
Liz Breen, Director of the Digital Health Enterprise Zone (DHEZ), University of Bradford, Reader in Health Service Operations, University of Bradford
When the Russian president, Vladimir Putin, announced on August 11 2020 that the country’s health regulator had become the first in the world to approve a COVID-19 vaccine for widespread use, the news was greeted with scepticism. No trials had been completed on the vaccine’s safety and efficacy.
While the initial reception of Sputnik V was critical, in February 2021, preliminary results of the phase 3 trials were reported with a 91.6%…
Read complete article
© The Conversation
- Tuesday, April 20, 2021